Cancer Treatment and Research Communications (CTRC)

Cancer Treatment and Research Communications is an international peer-reviewed journal dedicated to providing comprehensive basic, translational, and clinical oncology research. The journal is devoted to articles on detection, diagnosis, prevention, and treatment of cancer and provides a global forum for the nurturing and development of future generations of oncology scientists. Specific areas of interest include basic, translational, and clinical research and mechanistic approaches in all tumor types; cancer biology; molecular carcinogenesis; cancer genetics and genomics; cancer stem cells; molecular and cellular oncology; systems biology; immuno-oncology; chemoprevention strategies; gene and antisense therapy; the pathology of cancer, prognostic and predictive markers; drug sensitivity and resistance and novel treatment strategies to impact patient care. The journal also accepts clinical studies in oncology, with an emphasis on prospective early phase clinical trials.

Cancer Treatment and Research Communications (CTRC) is :-

• International, Peer-Reviewed, Open Access, Refereed, Cancer Research, Oncology, translational, and clinical research and mechanistic approaches in all tumor types, cancer biology, molecular carcinogenesis, cancer genetics and genomics, cancer stem cells, molecular and cellular oncology, systems biology, immuno-oncology , Online , Quarterly Journal

• UGC Approved, ISSN Approved: P-ISSN E-ISSN: 2468-2942, Established: 2016, Impact Factor: 2.4
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE